HCTI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Healthcare Triangle Inc (HCTI) is not a strong buy at this moment for a beginner investor with a long-term focus. The technical indicators show bearish trends, and the pre-market price is down significantly (-4.01%). While there are positive developments in the company's expansion into the GCC and revenue growth, the financials still show significant losses, and there is no strong trading signal to justify immediate action.
The MACD is positive but contracting, suggesting weakening momentum. RSI indicates the stock is oversold (11.552), but moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its key support level (S1: 2.792), with limited upside potential based on resistance levels (R1: 7.674).
The company has launched operations in Dubai's Meydan Free Zone, focusing on digital mental health solutions and healthcare modernization in the GCC. Revenue increased by 44.59% YoY in Q3 2025.
The pre-market price is down 4.01%, and the stock is trading in a bearish trend. Net income remains negative (-$1,906,000), and EPS has dropped significantly (-99.22% YoY).
In Q3 2025, revenue increased by 44.59% YoY to $3,489,000, and gross margin improved slightly to 15.91%. However, net income remains negative (-$1,906,000), and EPS dropped significantly to -25.73, indicating ongoing financial struggles.
No analyst rating or price target changes available for HCTI.
